We designed normal skin, AD-like skin (IL-4/IL-13-treated RHE),and treated AD lesion-like skin (anti- IL4Rα or ruxolitinib-treated IL-4/IL-13 RHE) using a 3D skin model. Here, IL13 is linked to Alzheimer disease.